ISee3D Enters Agreement to Commercialize 3D in advanced laser imaging systems

Toronto, ON, Canada - June 30, 2010 - ISee3D Inc. (TSX-V: ICT) announced today that it has entered into a license agreement with Hamilton Thorne Ltd., a leading provider of advanced laser systems and instruments for in-vitro cell applications.

Hamilton Thorne will combine commercial microscopes with their advanced laser imaging systems, utilizing ISee3D's patented single-lens single camera 3D technology, for stem cell regenerative medicine and fertility clinic markets worldwide. ISee3D and Hamilton Thorne are collaborating on prototype development with one of the world's leading lens and microscope designers and manufacturers, with the objective of having a commercial product ready for sale in 2011.

"This agreement with Hamilton Thorne lays out a clear commercialization path for microscopes empowered with our single-lens single camera 3D technology," said ISee3D CEO Dwight Romanica. "We look forward to working with Hamilton Thorne, and our design and manufacturing partner, on development of both a prototype and a leading commercially ready single-lens single camera 3D microscope."

"Our research customers have long sought a simple and cost effective method to incorporate true 3D images into their laser applications," says Meg Spencer, Hamilton Thorne CEO. "I believe that the extraordinary quality of the image in the ISee3D technology will represent a major advantage to researchers in the IVF and stem cell fields."

Under the terms of the agreement, ISee3D has granted Hamilton Thorne exclusive worldwide rights, for a three-year period, to commercialize a product, incorporating ISee3D's single-lens 3D technology in their laser imaging systems used in stem cell regenerative medicine and fertility clinic markets worldwide. Hamilton Thorne has agreed to pay ISee3D a one-time license fee of $150,000.00 USD, in addition to a royalty on each unit sold. Under the agreement, ISee3D is also guaranteed a minimum annual royalty.

###

About ISee3D
ISee3D is driving the universal adoption of 3D single lens capture – from consumers and Hollywood to health care and military. The company is introducing the first commercially feasible single lens, single camera 3D capture technology. Scalable in size from one mm in diameter to more than 250 mm, the patented technology can be applied across many devices. Through its patented optical switch technologies, ISee3D continues to aggressively pursue the best in 3D innovation to ensure an immersive 3D viewing experience, rather than the traditional two lenses or 2D conversion approaches that are the current standard. The company is headquartered in Vancouver with offices in Toronto.

 

Corporate Contact Tom Dalrymple, Chief Operating Officer ISee3D Inc. Office: 416-848-6353 tdalrymple@isee3d.com